Invention Grant
US08758733B2 Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
有权
使用前列腺素F2α激动剂化疗的局部治疗诱发睫毛损失或减轻症状
- Patent Title: Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
- Patent Title (中): 使用前列腺素F2α激动剂化疗的局部治疗诱发睫毛损失或减轻症状
-
Application No.: US13738732Application Date: 2013-01-10
-
Publication No.: US08758733B2Publication Date: 2014-06-24
- Inventor: Gurpreet Ahluwalia , Frederick C. Beddingfield , Sydney G. Edwards , Scott M. Whitcup
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Lorenz Siddiqi
- Main IPC: A61K8/00
- IPC: A61K8/00
Abstract:
The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
Public/Granted literature
Information query
